Jiaming Yu
Impact in
-
- CRISPR and Genetic Engineering
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
Papers in
-
- Fibroblast Growth Factor Research 2
- Viral Infectious Diseases and Gene Expression in Insects 2
- RNA Interference and Gene Delivery 2
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- Co-authors
- Yixuan Qiu (6 shared papers)Zhijun Bao (6 shared papers)Lian He (1 shared paper)Mengjuan Xue (5 shared papers)Yubin Zhou (1 shared paper)Peng Tan (1 shared paper)Wei Zhao (6 shared papers)Xueying Ji (5 shared papers)
- Journals
- Cell Death and Disease (2 papers)Mechanisms of Ageing and Development (1 paper)Frontiers in Neurology (1 paper)ACS Applied Materials & Interfaces (1 paper)Clinical and Translational Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jiaming Yu
32 papers receiving 1.1k citations
Jiaming Yu's Hit Papers
Peers
Comparison fields: 5 of 115
- Business and International Management 24
- Molecular Biology 695
- Biochemistry 37
- Cancer Research 78
- Immunology 83
Countries citing papers authored by Jiaming Yu
This map shows the geographic impact of Jiaming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaming Yu more than expected).
Fields of papers citing papers by Jiaming Yu
This network shows the impact of papers produced by Jiaming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaming Yu. The network helps show where Jiaming Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaming Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules Hit paper breakdown → | 2019 | 388 |
| 2 | 2019 | 105 | |
| 3 | 2021 | 91 | |
| 4 | 2021 | 74 | |
| 5 | 2022 | 73 | |
| 6 | 2021 | 64 | |
| 7 | 2018 | 46 | |
| 8 | 2022 | 36 | |
| 9 | 2024 | 29 | |
| 10 | 2020 | 25 | |
| 11 | 2021 | 23 | |
| 12 | 2023 | 23 | |
| 13 | 2023 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2020 | 19 | |
| 16 | 2019 | 18 | |
| 17 | 2020 | 17 | |
| 18 | 2022 | 9 | |
| 19 | 2025 | 6 | |
| 20 | 2021 | 6 |
About Jiaming Yu
Jiaming Yu is a scholar working on Immunology, Molecular Biology, Physiology, Computer Networks and Communications and Ophthalmology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Wireless Networks and Protocols (4 papers), Nutrition and Health in Aging (3 papers), Cancer Research and Treatments (2 papers), Fibroblast Growth Factor Research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), RNA Interference and Gene Delivery (2 papers), RNA modifications and cancer (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Business and International Management (24 citations), Molecular Biology (695 citations), Biochemistry (37 citations), Cancer Research (78 citations) and Immunology (83 citations). Jiaming Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yixuan Qiu, Zhijun Bao, Lian He, Mengjuan Xue, Yubin Zhou, Peng Tan, Wei Zhao, Xueying Ji, Fan Zhang and Huiyuan Yu. Their work appears in journals such as Cell Death and Disease, Mechanisms of Ageing and Development, Frontiers in Neurology, ACS Applied Materials & Interfaces and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.